Bevacizumab and irinotecan treatment for progressive diffuse brainstem glioma: case report.
J Neurooncol
; 93(3): 409-12, 2009 Jul.
Article
em En
| MEDLINE
| ID: mdl-19139822
ABSTRACT
Diffuse brainstem glioma carries a dismal prognosis. The current cornerstone of treatment is radiation therapy. Chemotherapy appears to be ineffective and the role of this treatment in the recurrent or progressive setting is not known. Bevacizumab and irinotecan have been reported to have shown radiographic response and improvement in progression-free survival among patients with malignant supratentorial gliomas. In this paper, we report our experience in an adult patient with progressive diffuse brainstem glioma treated with bevacizumab and irinotecan.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Protocolos de Quimioterapia Combinada Antineoplásica
/
Neoplasias do Tronco Encefálico
/
Glioma
Tipo de estudo:
Prognostic_studies
Limite:
Adult
/
Female
/
Humans
Idioma:
En
Revista:
J Neurooncol
Ano de publicação:
2009
Tipo de documento:
Article